Handbook of Safety Assessment of Nanomaterials
307,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
154 °P sammeln
  • Gebundenes Buch

This handbook, written by leading international experts, provides an overview of the state of the art of safety assessment of nanomaterials in context of their application in nanomedicine. The volume includes a historical perspective on the development of nanomedicine(s) and their regulation, and a personal view of the future of (nano)medicine by Patrick Hunziker, president of the European Society of Nanomedicine. The volume includes a series of chapters on organ-specific toxicities of nanomaterials, including pulmonary and cardiovascular toxicity, neurotoxicity, dermatotoxicity, and…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
This handbook, written by leading international experts, provides an overview of the state of the art of safety assessment of nanomaterials in context of their application in nanomedicine. The volume includes a historical perspective on the development of nanomedicine(s) and their regulation, and a personal view of the future of (nano)medicine by Patrick Hunziker, president of the European Society of Nanomedicine. The volume includes a series of chapters on organ-specific toxicities of nanomaterials, including pulmonary and cardiovascular toxicity, neurotoxicity, dermatotoxicity, and reproductive toxicity, as well as a discussion on immunotoxicity and genotoxicity.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Bengt Fadeel is professor of medical inflammation research at the Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, and adjunct professor of environmental and occupational health, University of Pittsburgh, Pittsburgh, PA, as well as visiting professor at the University of Rome "Tor Vergata" in Rome, Italy. He obtained his M.D. and Ph.D. from Karolinska Institutet. He received a six-year Senior Investigator Award in Inflammation Research from the Swedish Research Council and the national Environmental Medicine Prize in 2011 for research on the risks and opportunities of nanotechnology. Dr. Fadeel is a Fellow of the US Academy of Toxicological Sciences (ATS), director of the Nanosafety & Nanomedicine Laboratory, and head of the Division of Molecular Toxicology at the Institute of Environmental Medicine. He is the past coordinator of the FP7-NANOMMUNE consortium, which focused on the hazardous effects of engineered nanomaterials on the immune system, and is currently engaged in several other nanosafety projects, including FP7-MARINA, FP7-NANOREG, FP7-NANOSOLUTIONS, and FP7-SUN, as well as the European Flagship Project GRAPHENE, and the national MISTRA Environmental Nanosafety consortium. Dr. Fadeel served as co-chair of the 7th International Nanotoxicology Congress in Antalya, Turkey (2014).